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It was found that the activities of prooxidant enzymes (NAD(P)H oxidases and NAD(P)H:cytochrome c reductases) in bovine leukemia virus- 
transformed calf and lamb embryo kidney fibroblasts (lines Mi-18 and FLK) were by 1.25-18 times higher when compared to corresponding 
nontransformed calf cells. The activity of DT-diaphorase was also increased by about one order of magnitude in transformed cells. The activities 
of antioxidant enzymes were almost unchanged (superoxide dismutase), decreased by 13% or 53% (catalase) or increased by 25% or 90% (glutathione 
reductase) in Mi-18 or FLK cells, respectively. These changes of enzyme activity increased the toxicity of simple redox-cycling quinones (duroqui- 
none, naphthazarin) towards transformed cells, but did not affect the toxicity of daunorubicin. The latter was most probably related to the inhibition 
of plasma membrane NADH dehydrogenase. 
Bovine leukemia virus; Cell transformation: Quinone cytotoxicity 
1. INTRODUCTION 
Anthracycline quinones are important anticancer 
agents [l-6]. Some mechanisms of their cytotoxicity are 
related to the interaction with redox enzymes. One of 
the mechanisms is the redox cycling mediated by vari- 
ous NAD(P)H-oxidizing flavin dehydrogenases, lead- 
ing to the formation of reactive oxygen species [1,2]. 
Another mechanism of their action is the inhibition of 
plasma membrane NADH dehydrogenase [4-61. 
It is generally accepted that tumours and virus-trans- 
formed cells possess increased prooxidant activities, i.e. 
decreased activities of antioxidant enzymes superoxide 
dismutase (EC 1.15.1.1) and catalase (EC 1.11.1.6) [77 
111, thus sometimes making these cells more susceptible 
to the redox cycling of quinoidal compounds [7,11]. The 
content of glutathione peroxidase (EC 1.19.1.9) also 
decreases during transformation but the content of glu- 
tathione reductase (EC 1.6.4.2) is highly variable 
[10,12]. Some data show that the activities of certain 0;’ 
and H,O, generating enzymes, e.g. plasma membrane 
NADH oxidase [13] or the peroxisomal fatty acid /?- 
oxidation enzyme system [ 141 are higher in transformed 
cells. The increased activities of these or similar redox 
enzymes, catalyzing the redox cycling of quinonones 
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may also increase their cytotoxicity. On the other hand, 
cell tranformation may change the activity of plasma 
membrane NADH dehydrogenase and increase its sen- 
sitivity to anthracyclines [4-61. Thus the cell transfor- 
mation is accompanied by complex changes of enzyme 
activity, which complicate the discrimination between 
the mechanisms of toxicity of anthracyclines or the eval- 
uation of their contribution. 
In the present paper, we demonstrate that two lines 
of bovine leukemia virus (BLV)-transformed fibroblasts 
possess significantly higher activities of prooxidant en- 
zymes as compared to nontransformed cells, whereas 
the activities of antioxidant enzymes were almost un- 
changed. The influence of these enzymatic changes to- 
wards the cytotoxicity of quinones, including anthracy- 
cline antibiotic daunorubicin was investigated. 
2. MATERIALS AND METHODS 
The cultures of calf embryo kidney fibroblasts and their BLV- 
transformed line (Mi-18) and BLV-transformed lamb embryo kidney 
fibroblasts (line FLK) were grown and maintained in Eagles medium 
supplemented with 10% fetal bovine serum as described previously 
[15-l 71. For enzymatic analysis, the cells were grown until confluency, 
detached by trypsinization, twice washed with 0.1 M K-phosphate, pH 
7.4, containing 1 mM EDTA, and sonicated on ice in four cycles of 
20 s. The homogenate was centrifuged at 14,000 x g for 45 min and 
the resulting supernatant was used for enzymatic analysis. Protein 
determination was performed according to the method of Bradford 
[18]. For experiments using whole cells, after trypsinization, the cells 
were washed twice and finally suspended in Hanks’ balanced salt 
solution (pH 7.4) which was used during experiments. In cytotoxicity 
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experiments, cells were grown in the presence of various amounts of 
quinones, trypsinized and counted using a haemocytometer with via- 
bility determined by exclusion of Trypan blue. Unattached dead cells 
were removed prior to trypsinization. 
All spectrophotometric measurements were performed using a 
Hitach-557 spectrophotometer at 25°C. The activity of catalase was 
determined following the decomposition of 10 mM of H,O, in 0.1 M 
Tris-HCI, pH 8.0 [19]; the activity of superoxide dismutase was deter- 
mined using the xanthine oxidase-nitrobluetetrazolium assay at pH 7.8 
(0.1 M K-phosphate) [20]. The enzymatic reduction of cytochrome c 
(50 PM) or dichlorophenolindophenol (50 PM) by NAD(P)H (100 
PM) was monitored using As,,, = 20 mM_’ cm-r and A&,, = 21 
mM_’ cm-‘, respectively, in the absence or presence of 20 PM of 
dicumarol. In these assays, Tween 20 (0.01%) and bovine serum albu- 
min (0.25 mg ml-‘) were used as activators [21]. NAD(P)H:oxidase 
and NADPH:glutathione reductase activities were determined using 
A& 340 = 6.2 mM_’ cm-’ (concentration of NAD(P)H, 100 PM; con- 
centration of glutathione, 300 PM). These assays were performed in 
0.1 M K-phosphate, pH 7.0, containing 1 mM EDTA. The reduction 
of ferricyanide (0.125 mM) by whole cells was measured using the dual 
wavelength mode by substracting the change in absorbance at 500 nm 
from change at 420 nm, using de,,, = 1 .O mM_’ cm-’ [6]. Typically, 
concentrations of ca. lo6 cells ml-’ were used. 
Daunorubicin was purchased from Minmedprom (Russia), naph- 
thazarin from Fluka AG, all other enzymes and reagents from Sigma 
and Serva. 
3. RESULTS 
The data in Table I indicate that the activities of 
certain redox enzymes were markedly changed in BLV- 
transformed fibroblasts when compared with nontrans- 
formed ones. The NADH oxidase and NADPH:- 
dichlorophenoloindophenol reductase activities were 
Table I 
The activities of prooxidant and antioxidant enzymes in lysates of 
nontransformed and BLV-transformed fibroblasts 
Enzyme activity Cell line 
Nontrans- Mi-18 
formed 
FLK 
NADH:oxidase” 
NADPH:oxidase” 
NADH:cytochrome c 
reductased 
NADPH:cytochrome c 
reductase” 
NADPH:dichlorophenol- 
indophenol reductase” 
(- dicumarol) 
(+ dicumarol) 
Glutathione reductase” Catalaseb 
Superoxide dismutasec 
22 ? 2.4 400 ? 20 359 + 5 
8fl 102 1 43 f 6 
42 f 1 110+7 141 f8 
9.6 f 1 30 + 2 43 f 1 
42? 3 453 f 53 502 + 44 
22? 3 290? 43 246 f 24 
28 * 4 35 * 5 53 f 4 
44 t 2 38f 1 21 f 1 
14 * 2 13.5 f 2 1322 
d nmol mg protein-’ min-‘; 
bpmol mg protein’ mini’; 
’ units mg protein’; one unit of enzyme activity is defined as amount 
of protein needed to inhibit the rate of reduction of nitrobluetetra- 
zolium by 50%. 
Results are means from 3-4 determinations ? S.D 
J 
123456 
t (days) 
Fig. I. The effect of daunorubicin on the growth of BLV-transformed 
fibroblasts (line FLK). Concentratin of daunorubicin, 0 (I), 0.01 PM 
(2) 1.0 PM (3). Results are means from 34 determinations f SD. 
increased about by one order of magnitude, the latter 
being partially sensitive to dicumarol, a specific inhibi- 
tor of DT-diaphorase (EC 1.6.99.2) [21]. Thus, an in- 
crease of content of DT-diaphorase in transformed cells 
could be identified unequivocally. The activities of 
NAD(P)H:cytochrome c reductase and NADPH oxi- 
dase increased up to 5.4 times in transformed cells. 
NAD(P)H oxidase activities were insensitive to ro- 
tenone (2 PM) or azide (1 mM). They could be evidently 
attributed to O;‘-generating NAD(P)H oxidases of the 
plasma membrane [13,22,23], since according to the 
used method of lysate preparation, the latter should 
include a fibroblast membrane fraction as well [22,23]. 
Besides, the reduction of cytochrome c is inhibited by 
40% by adding superoxide dismutase (30 ,ug . ml-‘), 
thus being partially mediated by superoxide. The activ- 
ities of antioxidant enzymes, however, were changed 
less markedly in transformed cells. The activity of su- 
peroxide dismutase was almost unchanged, the activity 
of catalase was decreased by 13% or 53%, and that of 
glutathione reductase was even increased by 25% or 
90% (Table I). 
The addition of 10 PM naphthazarin (5,8-dihydroxy- 
1,4_naphthoquinone) or 100 PM duroquinone 
(tetramethyl- 1,4-benzoquinone) to reaction mixtures in- 
creased the corresponding rates of oxidation of 
NAD(P)H (Table I) and superoxide dismutase-sensitive 
reduction of cytochrome c by 2-2.5 times for all cell 
lysates investigated. It means, that redox cycling of 
these quinones leading to the formation of superoxide 
takes place. On the other hand, 100 PM of daunorubicin 
did not stimulate these reactions noticeably. 
The effect of daunorubicin on the growth of FLK 
cells is presented in Fig. 1. It is evident that even low 
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concentrations of this compound (< 1 PM) are highly 
cytotoxic, especially during long incubation. The same 
effects were also observed for nontransformed fibrob- 
lasts. However, after 24 h growth the toxicity of dauno- 
rubicin was similar both to transformed and nontrans- 
formed cells, showing an LD,, close to 1 ,uM in all cases 
(Fig. 2). On the other hand, LD,, of naphthazarin and 
duroquinone towards transformed cells were by 2-5 
times lower as compared to the nontransformed ones 
(Fig. 3). 
The reduction of ferricyanide by whole cells is cata- 
lyzed by NADH dehydrogenase of the plasma mem- 
brane which is also associated with NADH oxidase ac- 
tivity [4-61. We have found, that nontransformed, FLK 
and Mi- 18 cells reduce ferricyanide with corresponding 
rates of 1.0 2 0.2,0.9 & 0.2 and 2.5 + 0.5 nmol ferricya- 
nide . min-’ . (1 O6 cells)-‘. The inhibition of this reac- 
tion by daunorubicin is analogous for all cells tested, 
showing a CI,, close to 20 ,uM in all cases (Fig. 4). 
4. DISCUSSION 
The data of the present work indicate that the trans- 
formation of fibroblasts by BLV is accompanied by an 
increase of their prooxidant properties, i.e. increase of 
contents of prooxidant enzymes (NAD(P)H oxidases 
and cytochrome c reductases) while the antioxidant ac- 
tivity was almost unchanged (Table I). This is in con- 
trast to most described cases where the activities of 
antioxidant enzymes were markedly decreased [7-l 11. 
We think that the data of Table I may also predict 
insignificant changes in activities of other enzymes re- 
lated to the glutathione cycle. It was established that 
during the transformation of fibroblasts, the activity of 
1 
00 
[Daunorubicin] (pM) 
Fig. 2. Survival of fibroblasts after 24 h of growth in the presence of 
various concentrations of daunorubicin. Nontransformed cells (1) 
Mi-18 (2) and FLK (3). 
glutathione peroxidase parallels the changes in activity 
of superoxide dismutase, and the activity of glucose-6- 
phosphate dehydrogenase (EC 1.1.1.49) parallels that of 
glutathione reductase [12]. The increase in NAD(P)H 
oxidase activities may be related to the stimulating role 
of low concentrations of reactive oxygen species in cell 
proliferation [24,25], since transformed cells usually 
proliferate more rapidly. These changes in enzyme ac- 
tivity increased the rates of redox cycling of naphthaz- 
arin and duroquinone and, evidently, their toxicity to 
[Quinonel (uM) 
Fig. 3. Survival of fibroblasts after 24 h of growth in the presence of various concentrations of naphtharazin (A) and duroquinone (B). 
Nontransformed cells (I), Mi-18 (2) and FLK (3). 
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Fig. 4. The effect ofdaunorubicin on ferricyanide (0.125 mM) reduc- 
tion by nontransformed (1), Mi-I8 (2) and FLK (3) cells. 
t r ans fo rmed  cells (Fig.  3). However ,  the t r ans fo rma t ion  
has not  affected the toxici ty  of  daunorub ic in  (Fig.  2) 
which was as high as that  o f  naph thaza r in  (Fig.  3) de- 
spite a much lower rate  o f  redox cycling. Thus  ano the r  
mechan i sm of  daunorub ic in  toxici ty  prevails  in this 
case. It seems that  the la t ter  was also no t  affected by  an 
increased conten t  o f  DT-d i apho ra se  in t r ans fo rmed  
cells (Table I). Tha t  rules out  any specific con t r ibu t ion  
o f  DT-d iaphorase ,  e.g. fo rma t ion  o f  a lky la t ing  qu inom-  
ethide af ter  a two-elec t ron reduct ion  [3] to the toxici ty 
o f  daunorub ic in .  Besides, it was shown that  the reduc-  
t ion o f  daunorub ic in  by DT-d i apho ra se  is accompan ied  
by the redox cycling o f  h y d r o q u i n o n e  leading to the 
fo rma t ion  o f  ac t iva ted  oxygen species [21], ra ther  than  
by o ther  react ions.  The  ana logous  p roox idan t  act ivi ty  
o f  DT-d i apho ra se  was demons t r a t ed  dur ing  the reduc-  
t ion o f  naph thaza r i n  [26]. I t  seems tha t  the prevai l ing  
mechan i sm of  daunorub ic in  toxici ty in this case is the 
inhibi t ion  o f  p l a sma  m e m b r a n e  N A D H  dehydrogenase ,  
since its equal  toxici ty to t r ans fo rmed  and non t rans -  
fo rmed  cells (Fig. 2) paral le ls  the pa t te rns  o f  inhibi t ion  
(Fig. 4). This  conclus ion  is suppor t ed  by studies on 
hepatocytes ,  their  s imian v i rus - t r ans fo rmed  line and 
h e p a t o m a  [4], where the efficiency o f  inhib i t ion  o f  their  
p l a sma  m e m b r a n e  N A D H  dehydrogenase  by adr i amy-  
cin was paral le l  to its cytotoxici ty .  
I t  was shown tha t  i sola ted N A D ( P ) H - o x i d i z i n g  fla- 
voenzymes  reduce anthracycl ines  m a r k e d l y  s lower than  
quinones  with more  posi t ive single-electron reduct ion  
potent ia ls ,  e.g. naph thaza r i n  [27,28]. A n a l o g o u s  da t a  
were ob ta ined  for the reduct ion  o f  quinones  by  hepa to-  
cytes, where their  cytotoxici t ies  para l le led  the rates o f  
their  redox cycling [29]. The d a t a  o f  the present  work  
indicate  that  if  cy to toxic i ty  o f  an thracycl ines  is higher  
than  expected f rom the rates  o f  their  redox cycling, it 
m a y  be re la ted to the inhibi t ion  o f  p l a sma  m e m b r a n e  
N A D H  dehydrogenase .  
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